UnknownEarly Phase 1

Comparison of Sedative Effect of Dexmedetomidine and Midazolam for TIVA

60 participantsStarted 2023-01-01

Plain-language summary

Comparison of sedative effects of dexmedetomidine and midazolam using ramsay sedation scores intraoperatively in children undergoing inguinal hernia repair.

Who can participate

Age range6 Years – 12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ASA I and II Age 6 to 12 years Any gender Exclusion Criteria: * ASA III and above Age less than 2 years and above 12 years Congenital heart disease Cardiac arrythmias Congenital abnormalities Respiratory disease Endocrine disorders Mental retardation Organ dysfunction Bleeding disorders Physician or family refusal Previous surgeries Allergy to any drug

What they're measuring

Dexmedetomidine is better sedative agent than midazolam in pediatric population

Timeframe: 25 minutes

Trial details

NCT IDNCT05574179

SponsorSheikh Zayed Medical College

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2023-07-31

View on ClinicalTrials.gov More Choosing Better Drug Option for Sedation in Pediatric Population Intraoperatively trials